Jason Karlawish spoke with Better Health While Aging, highlighting new Alzheimer’s treatments such as lecanemab and donanemab. He discussed their effectiveness, side effects, and the pivotal role biomarkers play in diagnosing and managing the disease.
Citation:
"Inside Alzheimer’s Research: New Medications and Innovative Care," Better Health While Aging, 13 December, 2024